Suppr超能文献

BRAF突变的异质性分布支持多灶性乳头状甲状腺癌中不同肿瘤灶的独立克隆起源。

The heterogeneous distribution of BRAF mutation supports the independent clonal origin of distinct tumor foci in multifocal papillary thyroid carcinoma.

作者信息

Giannini Riccardo, Ugolini Clara, Lupi Cristiana, Proietti Agnese, Elisei Rossella, Salvatore Giuliana, Berti Piero, Materazzi Gabriele, Miccoli Paolo, Santoro Massimo, Basolo Fulvio

机构信息

Departments of Surgery, University of Pisa, 56126 Pisa, Italy.

出版信息

J Clin Endocrinol Metab. 2007 Sep;92(9):3511-6. doi: 10.1210/jc.2007-0594. Epub 2007 May 29.

Abstract

CONTEXT

Papillary thyroid carcinoma (PTC) is frequently multifocal. Independent PTC foci may occur either from intraglandular metastases from a single dominant tumor or as unrelated neoplastic clones. In rare cases, the simultaneous presence of PTC foci of different histopathological subtypes points to independent sites of tumor formation.

OBJECTIVES

We examined the pattern of BRAF mutations in noncontiguous tumor foci and node metastases from 69 patients affected by multicentric PTC. These included 19 cases characterized by the simultaneous presence of different PTC histopathological variants.

DESIGN

BRAF (exon 15) mutation was examined by PCR-single strand conformational polymorphism followed by DNA sequencing in laser-capture microdissected tissue samples.

RESULTS

Discordant patterns of BRAF mutation were found in about 40% of the multifocal PTCs. In node metastases, BRAF mutations were, in most but not all the cases, concordant with the dominant tumor. A discordant pattern of BRAF mutation was also found in about 50% of the cases in which multiple foci of different histopathological variants were present.

CONCLUSIONS

The heterogeneous distribution of BRAF mutations suggests that discrete tumor foci in multifocal PTC may occur as independent tumors. This information has to be considered in the design of targeted therapeutic approaches with BRAF pathway inhibitors.

摘要

背景

甲状腺乳头状癌(PTC)常为多灶性。独立的PTC病灶可能源于单个优势肿瘤的腺内转移,也可能是不相关的肿瘤克隆。在罕见情况下,不同组织病理学亚型的PTC病灶同时存在提示肿瘤形成的独立部位。

目的

我们检测了69例多中心性PTC患者非相邻肿瘤病灶和淋巴结转移灶中的BRAF突变模式。其中包括19例同时存在不同PTC组织病理学变异的病例。

设计

采用聚合酶链反应-单链构象多态性(PCR-SSCP)结合DNA测序技术,对激光捕获显微切割的组织样本进行BRAF(第15外显子)突变检测。

结果

在约40%的多灶性PTC中发现BRAF突变模式不一致。在淋巴结转移灶中,大多数(但并非所有)病例的BRAF突变与优势肿瘤一致。在约50%存在不同组织病理学变异多个病灶的病例中也发现了BRAF突变的不一致模式。

结论

BRAF突变的异质性分布提示多灶性PTC中的离散肿瘤病灶可能是独立发生的肿瘤。在设计BRAF通路抑制剂的靶向治疗方案时必须考虑这一信息。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验